Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
Retinopathy is a debilitating vascular complication of diabetes. As with other diabetic complications, diabetic retinopathy (DR) is characterized by the metabolic memory, which has been observed both in DR patients and in DR animal models. Evidences have provided that after a period of poor glucose...
Saved in:
Main Authors: | Lorena Perrone, Carmela Matrone, Lalit P. Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2014/789120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum to “Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy”
by: Lorena Perrone, et al.
Published: (2014-01-01) -
Oxidative Stress, Epigenetics, Environment, and Epidemiology of Diabetic Retinopathy
by: Goran Petrovski, et al.
Published: (2017-01-01) -
Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
by: Jing Sun, et al.
Published: (2017-01-01) -
Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
by: Cristina Hernández, et al.
Published: (2016-01-01) -
Update on the Treatment of Diabetic Retinopathy
by: Jennifer L. Wilkinson-Berka, et al.
Published: (2008-01-01)